© 2017 by RareFundingTeam

Rare Disease News

August 18, 2017

Research carried out on a Niemann-Pick type C1 (NPC1) treatment can lead to a new generation of potential therapies for NPC1 and other similar disorders, as well as neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases.

Please reload

Share your Rare Disease News

Send us rare disease news stories and we will post them on the site. Paste the web address into the message field and send.

Please reload

Follow Us
  • LinkedIn Social Icon
  • Facebook Basic Square
  • YouTube Social  Icon